Abaxis Inc. (ABAX) Stock Research, Analysis & News

Quick Analysis on Abaxis Inc. (ABAX) Stock as of August 24, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Abaxis Inc. (ABAX) Stock below)

Abaxis Inc. (ABAX) Stock Profile Summary

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements in the medical and veterinarian markets. Its products include point-of-care blood chemistry analyzer, which performs a panel of 14 tests on human patients and 13 tests on veterinary patients marketed under the Piccolo xpress and Piccolo Classic names in the human medical market, and under the VetScan VS2 and VetScan Classic names in the veterinary market. The companys products also include Reagent Discs that handle various technical steps of blood chemistry testing automatically; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, which offer blood count analysis for veterinary applications. In addition, its products comprise VetScan VSpro that assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular disease, hepatic disease, and monitoring therapy, as well as progression of disease states; VetScan canine heartworm rapid test, a test for the detection of dirofilaria immitis in canine whole blood, serum, or plasma; and i-STAT 1 analyzer, a handheld instrument and associated consumables for blood gas, electrolyte, basic blood chemistry, and immunoassay testing for the animal health care market. Further, Abaxiss products consist of Orbos Discrete Lyophilization process, which allows the production of active chemical ingredient in the form of a soluble bead, as well as involves in flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. The company markets and sells its products through a direct sales force and independent distributors world wide. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.

Abaxis Inc. (ABAX) Stock Key Statistics Research and Analysis as of August 24, 2019

Abaxis Inc. (ABAX) Stock Competitor Research and Analysis

Alere Inc. (ALR)IDEXX Laboratories, Inc. (IDXX)
Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)

Mutual Funds with Abaxis Inc. (ABAX) Stock in its top 10 holdings

FundCategoryABAX Holding Percentage
Alger Growth Opportunities ASmall Growth3.19%
Virtus Small-Cap Core ASmall Growth4.25%
Virtus Small-Cap Sustainable Growth ASmall Growth4.6%

Stock Research on Abaxis Inc. (ABAX)

Latest Market News on Abaxis Inc. (ABAX)


Click here to find the latest news on Abaxis Inc. (ABAX)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Alere Inc. (ALR)
IDEXX Laboratories, Inc. (IDXX)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)
Bristol-Myers Squibb Company (BMY)